lobbying_activities: 1880700

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1880700	ed881810-8108-4d57-b6b7-f2b8912605ce	Q3	EMPIRE CONSULTING GROUP	400703105	PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA	2016	third_quarter	PHA	Issues relating to Medicare Parts D and D; prescription drug costs/pricing; legislation and issues relating to opioids; budget.	HOUSE OF REPRESENTATIVES	40000		0	0	2016-10-17T21:33:54.513000-04:00